Literature DB >> 10689149

Immunity to influenza in the elderly.

R G Webster1.   

Abstract

Influenza is caused by a constantly varying segmented RNA virus that necessitates yearly review of vaccine composition. Humans over the age of 65 years are considered at high risk from influenza; during influenza epidemics the rate of hospitalization in the elderly is very high and up to 90% mortality can occur. Vaccination of the elderly has been shown to be efficacious and cost effective but immunological senescence in the institutionally confined frail elderly is demonstrated by failure to induce herd immunity after vaccination. Reductions in B- and T-cell immunity and in levels of interleukin-2 are age related. Attempts to increase the immunoresponsiveness of the elderly to influenza vaccines have given mixed results. The most convincing evidence is in rodents where dietary caloric restriction has been shown to enhance viral immunity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10689149     DOI: 10.1016/s0264-410x(99)00507-1

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  61 in total

1.  Childhood Hib vaccination and pneumonia and influenza burden in US seniors.

Authors:  Steven A Cohen; Saifuddin Ahmed; Ann C Klassen; Emily M Agree; Thomas A Louis; Elena N Naumova
Journal:  Vaccine       Date:  2010-05-08       Impact factor: 3.641

2.  The role of nutrition in enhancing immunity in aging.

Authors:  Munkyong Pae; Simin Nikbin Meydani; Dayong Wu
Journal:  Aging Dis       Date:  2011-09-30       Impact factor: 6.745

Review 3.  A challenge for the future: aging and HIV infection.

Authors:  Tammy M Rickabaugh; Beth D Jamieson
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

4.  Live attenuated influenza virus expressing human interleukin-2 reveals increased immunogenic potential in young and aged hosts.

Authors:  Boris Ferko; Christian Kittel; Julia Romanova; Sabine Sereinig; Hermann Katinger; Andrej Egorov
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

5.  Vulnerability, distress, and immune response to vaccination in older adults.

Authors:  Suzanne C Segerstrom; Jaime K Hardy; Daniel R Evans; Richard N Greenberg
Journal:  Brain Behav Immun       Date:  2011-10-29       Impact factor: 7.217

Review 6.  Homeostasis and the age-associated defect of CD4 T cells.

Authors:  Susan Swain; Karen Clise-Dwyer; Laura Haynes
Journal:  Semin Immunol       Date:  2005-10       Impact factor: 11.130

7.  Repeated influenza vaccination of healthy children and adults: borrow now, pay later?

Authors:  F Carrat; A Lavenu; S Cauchemez; S Deleger
Journal:  Epidemiol Infect       Date:  2006-02       Impact factor: 2.451

Review 8.  Intranasal cold-adapted influenza virus vaccine combined with inactivated influenza virus vaccines: an extra boost for the elderly?

Authors:  Paul V Targonski; Gregory A Poland
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

9.  Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge.

Authors:  Zhiyuan Wen; Ling Ye; Yulong Gao; Lei Pan; Ke Dong; Zhigao Bu; Richard W Compans; Chinglai Yang
Journal:  Antiviral Res       Date:  2009-09-20       Impact factor: 5.970

10.  An age-old paradigm challenged: old baboons generate vigorous humoral immune responses to LcrV, a plague antigen.

Authors:  Sue Stacy; Amanda Pasquali; Valerie L Sexton; Angelene M Cantwell; Ellen Kraig; Peter H Dube
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.